. Degree of glycosylation (mean ± SD) of the altered glycoforms in control, periductal fibrosis (PDF), and cholangiocarcinoma (CCA) subjects.
$ Glycoform
Degree of glycosylation (mean ± SD) Control PDF CCA 6503
3.6 ± 2.5 5.0 ± 2.8 7.9 ± 7.3 5422
2.1 ± 2.3 1.9 ± 1.4 3.9 ± 5.0 6502
3.8 ± 3.1 5.9 ± 4.7 13.0 ± 12.5 6511 0.6 ± 0.5 0.9 ± 0.6 0.8 ± 0.7 6521
1.5 ± 1.2 1.3 ± 1.4 3.2 ± 4.0 5402 0.7 ± 0.4 0.9 ± 0.5 0.9 ± 0.6 5412 0.7 ± 0.5 0.9 ± 0.5 1.2 ± 0.9 5421 0.7 ± 0.4 0.9 ± 0.6 0.9 ± 0.6 6501 17.6 ± 14.0 26.2 ± 13.3 42.4 ± 28.3 Table 3 . Association between levels of serotransferrin peptides and glycopeptides in the sera of CCA patients and clinicopathological data. 
